Identification, epidemiological relatedness, and biofilm formation of clinical Chryseobacterium indologenes isolates from central Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 48, Issue 5, 2015, Pages 559-564

  Chang, Yi Cheng ^a   Lo, Hsueh Hsia ^b   Hsieh, Hsiu Ying ^b   Chang, Shan Min ^a  

^a Fongyuan Hospital   (Taiwan)

^b CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Biofilm; Central Taiwan; Chryseobacterium indologenes; Epidemiological relatedness; Identification

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DNA FRAGMENT; GENTAMICIN; IMIPENEM; MINOCYCLINE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RNA 16S; BACTERIAL DNA; RIBOSOME DNA;

ACCURACY; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENETICS; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BIOFILM; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; CHRYSEOBACTERIUM; CHRYSEOBACTERIUM GLEUM; CHRYSEOBACTERIUM INDOLOGENES; COMPARATIVE STUDY; DIABETES MELLITUS; EPIDEMIOLOGY; FEASIBILITY STUDY; FEMALE; GENE SEQUENCE; GOLD STANDARD; HOSPITAL PATIENT; HUMAN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; SPECIES IDENTIFICATION; SPUTUM; TAIWAN; URINE; CHEMISTRY; CLASSIFICATION; DNA SEQUENCE; FLAVOBACTERIACEAE INFECTIONS; GENETICS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR TYPING; PHYSIOLOGY; RETROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL TYPING TECHNIQUES; BACTERIOLOGICAL TECHNIQUES; BIOFILMS; CHRYSEOBACTERIUM; DNA, BACTERIAL; DNA, RIBOSOMAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; FLAVOBACTERIACEAE INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; RETROSPECTIVE STUDIES; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TAIWAN;

EID: 84943587668     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2014.04.004     Document Type: Article

References (27)

1. Yabuuchi E., Hashimoto Y., Ezaki T., Ido Y., Takeuchi N. Genotypic and phenotypic differentiation of Flavobacterium indologenes Yabuuchi et al 1983 from Flavobacterium gleum Holmes et al. Microbiol Immunol 1984, 1990(34):73-76.
2. Hsueh P.R., Hsiue T.R., Wu J.J., Teng L.J., Ho S.W., Hsieh W.C., et al. Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clin Infect Dis 1996, 23:550-555.
3. Marcos Sanchez F., Plaza Diaz R., Juarez Ucelay F., Duran Perez-Navarro A. Pneumonia from Flavobacterium indologenes (group II B) in an immunodepressed patient. An Med Interna 1993, 10:312.
4. Hsueh P.R., Teng L.J., Ho S.W., Hsieh W.C., Luh K.T. Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices. J Clin Microbiol 1996, 34:1908-1913.
5. Afshar M., Nobakht E., Lew S.Q. Chryseobacterium indologenes peritonitis in peritoneal dialysis. BMJ Case Rep 2013, 10.1136/bcr-2013-009410.
6. Lu P.C., Chan J.C. Flavobacterium indologenes keratitis. Ophthalmologica 1997, 211:98-100.
7. Chen F.L., Wang G.C., Teng S.O., Ou T.Y., Yu F.L., Lee W.S. Clinical and epidemiological features of Chryseobacterium indologenes infections: analysis of 215 cases. J Microbiol Immunol Infect 2013, 46:425-432.
8. Lin Y.T., Jeng Y.Y., Lin M.L., Yu K.W., Wang F.D., Liu C.Y. Clinical and microbiological characteristics of Chryseobacterium indologenes bacteremia. J Microbiol Immunol Infect 2010, 43:498-505.
9. Woo P.C., Lau S.K., Teng J.L., Tse H., Yuen K.Y. Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories. Clin Microbiol Infect 2008, 14:908-934.
10. Saffert R.T., Cunningham S.A., Ihde S.M., Jobe K.E., Mandrekar J., Patel R. Comparison of Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometer to BD Phoenix automated microbiology system for identification of gram-negative bacilli. J Clin Microbiol 2011, 49:887-892.
11. Fernández-Olmos A., García-Castillo M., Morosini M.I., Lamas A., Máiz L., Cantón R. MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients. J Cyst Fibros 2012, 11:59-62.
12. Pan H.J., Teng L.J., Chen Y.C., Hsueh P.R., Yang P.C., Ho S.W., et al. High protease activity of Chryseobacterium indologenes isolates associated with invasive infection. J Microbiol Immunol Infect 2000, 33:223-226.
13. Donlan R.M., Costerton J.W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002, 15:167-193.
14. Lin P.Y., Chen H.L., Huang C.T., Su L.H., Chiu C.H. Biofilm production, use of intravascular indwelling catheters and inappropriate antimicrobial therapy as predictors of fatality in Chryseobacterium meningosepticum bacteraemia. Int J Antimicrob Agents 2010, 36:436-440.
15. Kodama Y., Nishimura M., Nakashima K., Ito N., Fukano R., Okamura J., et al. Central intravenous catheter-related bacteremia due to Chryseobacterium indologenes after cord blood transplantation. Rinsho Ketsueki 2013, 54:305-310.
16. Weisburg W.G., Barns S.M., Pelletier D.A., Lane D.J. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol 1991, 173:697-703.
17. Chang Y.C., Lo H.H., Hsieh H.Y., Chang S.M. Identification and epidemiological relatedness of clinical Elizabethkingia meningoseptica isolates from central Taiwan. J Microbiol Immunol Infect 2014, 47:318-323. 10.1016/j.jmii.2013.03.007.
18. M100-S24, performance standards for antimicrobial susceptibility testing; twenty-forth informational supplement 2014, Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute, Wayne, PA.
19. Stepanovic S., Vukovic D., Dakic I., Savic B., Svabic-Vlahovic M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods 2000, 40:175-179.
20. Hunter S.B., Vauterin P., Lambert-Fair M.A., Van Duyne M.S., Kubota K., Graves L., et al. Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard. J Clin Microbiol 2005, 43:1045-1050.
21. Hsueh P.R., Teng L.J., Yang P.C., Ho S.W., Hsieh W.C., Luh K.T. Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol Infect Dis 1997, 16:68-74.
22. Chou D.W., Wu S.L., Lee C.T., Tai F.T., Yu W.L. Clinical characteristics, antimicrobial susceptibilities, and outcomes of patients with Chryseobacterium indologenes bacteremia in an intensive care unit. Jpn J Infect Dis 2011, 64:520-524.
23. Vivas J., Padilla D., Real F., Bravo J., Grasso V., Acosta F. Influence of environmental conditions on biofilm formation by Hafnia alvei strains. Vet Microbiol 2008, 129:150-155.
24. Ceri H., Olson M.E., Stremick C., Read R.R., Morck D., Buret A. The Calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999, 37:1771-1776.
25. Kaufmann M.E. Pulsed-field gel electrophoresis. Molecular bacteriology: protocols and clinical applications 1998, 33-50. Humana Press, New Jersey. N. Woodford, A.P. Johnson (Eds.).
26. Aucken H.M., Boquete T., Kaufmann M.E., Pitt T.L. Interpretation of band differences to distinguish strains of Serratia marcescens by pulsed-field gel electrophoresis of XbaI DNA digests. Epidemiol Infect 2000, 125:63-70.
27. Lambiase A., Del Pezzo M., Raia V., Sepe A., Ferri P., Rossano F. Chryseobacterium respiratory tract infections in patients with cystic fibrosis. J Infect 2007, 55:518-523.